Page 86 - MemoriaCIBER-2018ENG

86
models: one of these at the IMIBIC (Cordoba)
on 13 April and the other at the Curie Institute
in Paris, in the setting of the Disease Maps Community Meeting, on 22 June. The BiER has also arranged a course on the analysis of genomic data “From reads to disease variants” with the
MAPER
In 2018 information for the MAPER database continued to be compiled. All the active clinical trials for rate diseases have been incorporated through cooperation with the Agencia Española de Medicamentos y Productos Sanitarios and other research and care resources of use for rare diseases and the future genomics plan.
The data on the validated research projects and clinical trials accessible over the MAPER web in
renowned group of the MIT which developed the GATK, covering the processes ranging from obtaining the primary data of the sequencer to the priorisation of variants (http://courseswiki. clinbioinfosspa.es/gatk2018/start).
2018 is as follows::
• 879 biomedical research projects included and 514 clinical tests compiled.
• 120 financing agencies taking part in financing the research into RD.
• 515 Principal Investigators included in the database.
• 241 research centres included.
• Presentation of results at the annual CIBERER meeting for 2018 and updating the MAPER website to incorporate the test search engine.
CIBERER | ANNUAL REPORT 2018